June 15, 2026
Archives
Deck Bio Launches Multi-Target T Cell Engager Platform for Solid Tumors, With Preclinical Data to be Presented at AACR 2026
B Emerging biotechnology company advancing multi-pMHC targeted T cell engagers to address tumor heterogeneity and resistance Differentiated approach integrates proprietary T cell receptor (TCR) specificity engineering and stabilization technologies to…
Life-Altering Impact for Liver Cancer Patients From a Non-Invasive Treatment
B PEMBROKE PINES, Fla., April 9, 2026 /PRNewswire/ — Brenda was all ears when she heard that sound waves could help her fight liver cancer. A new groundbreaking, non-invasive, alternative…
Spring Health Data Reveals a “Silent Burnout” Crisis: Mental Health Leaves Surge as Employees Quietly Disengage
B New research finds nearly two-thirds of HR leaders report a rise in mental health-related leaves, even as most believe their benefits are working NEW YORK, April 9, 2026 /PRNewswire/…
Black Duck Appoints Dom Glavach as Chief Information Security Officer
B Veteran security executive brings more than two decades of enterprise, SaaS, and national defense cybersecurity leadership to Black Duck BURLINGTON, Mass., April 9, 2026 /PRNewswire/ — Black Duck®, the leader in…
DeepCyte Raises $1.5M to Bring Single-Cell AI Toxicology to Drug Development
B WILMINGTON, Del. and COPENHAGEN, Denmark, April 9, 2026 /PRNewswire/ — DeepCyte, a techbio company building AI toxicology tools for drug development, launched today with $1.5 million in seed funding. The…
S4GEO ANNOUNCES ITS ADVISORY BOARD
B NEW YORK, April 9, 2026 /PRNewswire/ — S4GEO is pleased to announce the formation of its Advisory Board, which will support its mission to advance the practice of applied…
Aries’ Lead Investor Purchases Series 2019 and Series 2021 Bonds Strengthening Foundation for Linden Facility Redevelopment
B Transaction aligns investors, and positions project for the next phase FRANKLIN, Tenn., April 9, 2026 /PRNewswire/ — Aries Clean Technologies today announced its lead investor has purchased all the…
Eisai to Present the Latest Data on Real-World Treatment with Lecanemab and Supporting a Standardized Framework for Treating Early Alzheimer’s Disease at the 78th American Academy of Neurology’s Annual Meeting
B NUTLEY, N.J., April 9, 2026 /PRNewswire/ — Eisai Inc. announced today the company will present the latest findings on lecanemab (generic name, brand name: LEQEMBI®), Eisai’s anti-amyloid beta (Aβ)…
Appknox Launches KnoxIQ, an AI Co-Pilot to Prioritize Real-World Exploitability in Application Security
B New AI-native platform validates vulnerabilities, prioritizes real risk and delivers contextual remediation code inside developer workflows SINGAPORE, April 9, 2026 /PRNewswire/ — Appknox, a leading provider of cutting-edge mobile…
Oracle Brings New AI Agent-Driven Capabilities to its Industry-Leading Financial Crime and Compliance Portfolio
B Extends FCCM platform with next-generation AI technology for case management and investigation workflows NEW YORK, April 9, 2026 /PRNewswire/ — AI World – Oracle continues to strengthen its financial crime…